Principal component analysis of cytokine signature in COVID-19 and Long COVID

Zoia R Korobova1,2, Areg A Totolian1,2

  • 1Laboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, Saint Petersburg, Russia.

PubMed

Insights

Long COVID (LC) involves complex immune system dysregulation, with distinct cytokine clusters identified. These clusters highlight local immune responses, neuroinflammation, and vascular changes contributing to LC immunopathology.

Area of Science:

  • Immunology
  • Pathophysiology
  • Biomarker Analysis

Background:

  • Long COVID (LC) presents with diverse symptoms impacting multiple organ systems.
  • Cytokines are crucial biomarkers for assessing immune dysregulation in LC.
  • Traditional statistical methods struggle with complex multiplex cytokine analysis.

Purpose of the Study:

  • To analyze multiplex cytokine data from COVID-19 patients, LC patients, and healthy donors.
  • To identify key cytokine interactions and networks associated with Long COVID.
  • To elucidate the immunopathology underlying Long COVID through cytokine profiling.

Main Methods:

  • Multiplex cytokine analysis of serum samples from 289 COVID-19 patients, 44 LC patients, and 51 healthy donors.
  • Principal Component Analysis (PCA) to identify important cytokines.
  • 3D mapping for detailed investigation of identified cytokine clusters.

Main Results:

  • Three distinct cytokine clusters (A, B, C) were identified.
  • Cluster A: IL-13, CCL7/MCP-3, IL-4 (local immune responses).
  • Cluster B: IL-18, CCL2/MCP-1, CCL4/MIP-1β, CXCL8/IL-8, M-CSF (neuroinflammation).
  • Cluster C: sCD40L, CXCL1/GROα, PDGF-AA, EGF, FGF-2, FLT-3L, IL-7, IL-17F (vascular changes).

Conclusions:

  • Coordinated cytokine interactions within clusters reveal complex LC immunopathology.
  • Cluster A suggests local immune responses, Cluster B neuroinflammation, and Cluster C vascular changes.
  • Further research is needed for comprehensive interpretation of these findings.
Abstract